X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
tuberculosis (7) 7
drug resistance (5) 5
tuberculosis, multidrug-resistant - drug therapy (4) 4
abridged index medicus (3) 3
adult (3) 3
antitubercular agents - therapeutic use (3) 3
europe (3) 3
female (3) 3
male (3) 3
middle aged (3) 3
multidrug-resistant tuberculosis (3) 3
respiratory system (3) 3
treatment outcome (3) 3
tuberculosis, multidrug-resistant - epidemiology (3) 3
antitubercular agents (2) 2
article (2) 2
clinical outcomes (2) 2
cohort studies (2) 2
drug resistance in microorganisms (2) 2
europe - epidemiology (2) 2
hiv infections - complications (2) 2
incidence (2) 2
infectious and parasitic diseases (2) 2
infectious disease (2) 2
infectious diseases (2) 2
laboratories (2) 2
mycobacterium tuberculosis (2) 2
mycobacterium tuberculosis - drug effects (2) 2
mycobacterium tuberculosis - genetics (2) 2
mycobacterium tuberculosis - isolation & purification (2) 2
prospective studies (2) 2
rifampin (2) 2
risk (2) 2
tbnet (2) 2
tuberculosis, multidrug-resistant (2) 2
accuracy (1) 1
africa (1) 1
analysis (1) 1
antibiotics, antitubercular - pharmacology (1) 1
antitubercular agents - pharmacology (1) 1
antituberculosis drug (1) 1
asia (1) 1
assay (1) 1
bacteria (1) 1
bacteriological techniques - methods (1) 1
belarusian national surveillance database (1) 1
brazil (1) 1
california (1) 1
carbapenems (1) 1
carbapenems - therapeutic use (1) 1
care and treatment (1) 1
cellular therapy (1) 1
charities (1) 1
clinical protocols (1) 1
clofazimine (1) 1
clofazimine - therapeutic use (1) 1
coinfection - drug therapy (1) 1
coinfection - microbiology (1) 1
coinfection - virology (1) 1
communicable disease control - standards (1) 1
comorbidity (1) 1
complex (1) 1
critical care medicine (1) 1
cross-sectional studies (1) 1
data collection (1) 1
delamanid (1) 1
diagnostic systems (1) 1
diarylquinolines - therapeutic use (1) 1
disease-free survival (1) 1
diseases of the respiratory system (1) 1
drug resistance, bacterial (1) 1
drug therapy, combination (1) 1
drug-resistant tuberculosis (1) 1
drugs (1) 1
efficacy (1) 1
elimination (1) 1
ertapenem (1) 1
evaluation (1) 1
experience (1) 1
extensively drug resistant (1) 1
extensively drug-resistant tb (1) 1
extensively drug-resistant tuberculosis (1) 1
extensively drug-resistant tuberculosis - drug therapy (1) 1
germany (1) 1
history, 21st century (1) 1
hiv infections - drug therapy (1) 1
hiv infections - epidemiology (1) 1
human immunodeficiency virus--hiv (1) 1
hypersensitivity (1) 1
immunology (1) 1
isoniazid (1) 1
kaplan-meier estimate (1) 1
linezolid (1) 1
linezolid - therapeutic use (1) 1
management (1) 1
mdr tb (1) 1
mdr-tb (1) 1
medical education (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 76 - 84
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 05/2017, Volume 49, Issue 5, pp. 1700387 - 1700387
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 2015, Volume 21, Issue 3, pp. 409 - 416
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 06/2017, Volume 49, Issue 6, pp. 1602363 - 1602363
Journal Article
European Respiratory Journal, ISSN 0903-1936, 05/2017, Volume 49, Issue 5
Journal Article
International Journal of Mycobacteriology, ISSN 2212-5531, 2016, Volume 5, Issue 5, pp. S23 - S23
Abstract Background/Objective We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC)... 
Infectious Disease | Medical Education | Novel treatments | Mesenchymal stromal cell | Multidrug-resistant tuberculosis | Antituberculosis drug | Belarusian national surveillance database | Care and treatment | Tuberculosis | Methods | Cellular therapy
Journal Article
International journal of mycobacteriology, ISSN 2405-5794, 12/2016, Volume 5 Suppl 1, pp. S23 - 27
We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due... 
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 03/2015, Volume 21, Issue 3, pp. 409 - 416
Drug-resistant Mycobacterium tuberculosis is challenging elimination of tuberculosis (TB). We evaluated risk factors for TB and levels of second-line drug... 
Journal Article
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, ISSN 2405-5794, 2016, Volume 4, pp. 21 - 27
Abstract Introduction We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is... 
Infectious Disease | Mesenchymal stromal cells | Treatment | Extensively drug resistant | Outcomes | treatment | extensively drug resistant | outcomes | mesenchymal stromal cells
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.